- Recommendation ID
- IPG756/1
- Question
Evidence on the safety of focal therapy using high-intensity focused ultrasound for localised prostate cancer is adequate, but evidence on its efficacy is limited. Therefore, this procedure should only be used with special arrangements for clinical governance, consent, and audit or research. Find out what special arrangements mean on the NICE interventional procedures guidance page.
- Any explanatory notes
(if applicable) Further research could include registry data or randomised trials. It should include details of patient selection, including size and classification of tumour, technique used and long-term outcomes such as quality of life.
Source guidance details
- Comes from guidance
- Focal therapy using high-intensity focused ultrasound for localised prostate cancer
- Number
- IPG756
- Date issued
- April 2023
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 05/05/2023 |